Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:58 AM
Ignite Modification Date:
2025-12-26 @ 10:58 AM
NCT ID:
NCT00232206
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytologically confirmed NSCLC appropriate for surgery
* Medically fit for resection by lobectomy or pneumonectomy
* T1-2N1 disease by CT must have negative N2/N3 nodes by PET
* T3N1 disease must have pathologically negative N2/N3 nodes
* Measurable disease
* Patients must not be receiving other investigational therapy
* Prior surgery for NSCLC okay if resected \> or = 5 years prior
* No prior chemotherapy or radiation for NSCLC
* No uncontrolled medical problems
* No factors that would preclude obtaining informed consent
* Age 18 or greater
* Performance status (PS) 0-1
* Peripheral neuropathy must be \< grade 1
* Acceptable hematologic and chemistry parameters
* Renal: creatinine clearance (calculated) \> 50 cc/min
Exclusion Criteria:
* History of severe hypersensitivity to docetaxel or like drugs
* Pregnant or nursing women
* Prior chemotherapy or radiation for NSCLC
* Symptomatic superior sulcus tumors
* Prior malignancy except for treated non-melanoma skin cancer, in situ cervical cancer, localized prostate cancer or cancer from which the patient has been disease free for greater than three years
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00232206
Study Brief:
Protocol Section:
NCT00232206